News
Verge Genomics will use digital biomarkers to assess short-term disease progression in an ALS trial testing its VRG50635 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback